Qubigen Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 4

Qubigen General Information

Description

Developer of computational drug design technology designed for the development of novel targeted medicines. The company's technology leverages a global federated artificial intelligence system and proprietary workflows to securely analyze protected data, enabling pharmaceutical researchers to generate quality drug candidates efficiently, accelerate structure-activity relationship modeling, and access unique ADMET insights without exposing sensitive intellectual property, ultimately reducing time and resources required for drug discovery.

Contact Information

Website
www.qubigen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Bio21 Institute
  • 30 Flemington Road
  • Parkville, Victoria 3052
  • Australia
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Drug Discovery
Corporate Office
  • Bio21 Institute
  • 30 Flemington Road
  • Parkville, Victoria 3052
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Qubigen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 22-Mar-2025 Completed Generating Revenue
2. Seed Round 04-Dec-2024 Completed Generating Revenue
1. Joint Venture 02-Dec-2024 Completed Generating Revenue
To view Qubigen’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Qubigen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Qubigen Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
3Lines Venture Capital Minority
SYNthesis BioVentures Venture Capital Minority
Presagen VC-Backed Company Majority
Qubist Corporation Majority
To view Qubigen’s complete investors history, request access »

Qubigen FAQs

  • When was Qubigen founded?

    Qubigen was founded in 2024.

  • Where is Qubigen headquartered?

    Qubigen is headquartered in Parkville, Australia.

  • What is the size of Qubigen?

    Qubigen has 7 total employees.

  • What industry is Qubigen in?

    Qubigen’s primary industry is Discovery Tools (Healthcare).

  • Is Qubigen a private or public company?

    Qubigen is a Private company.

  • What is Qubigen’s current revenue?

    The current revenue for Qubigen is .

  • Who are Qubigen’s investors?

    3Lines, SYNthesis BioVentures, Presagen, and Qubist have invested in Qubigen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process